805.37

2.93% -24.33

After Hours: 805.60 0.23 +0.03%

Mckesson Corporation (MCK)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Mckesson Corporation stock is traded at $805.37, with a volume of 1.48M. It is down -2.93% in the last 24 hours and down -1.82% over the past month. McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Previous Close:

$829.70

Open:

$835.39

24h Volume:

1.48M

Relative Volume:

2.03

Market Cap:

$99.40B

Revenue:

$387.09B

Net Income/Loss:

$4.23B

P/E Ratio:

25.07

EPS:

32.1208

Net Cash Flow:

$6.01B

1W Performance:

-8.86%

1M Performance:

-1.82%

6M Performance:

+12.66%

1Y Performance:

+30.33%

1-Day Range:

$802.72

$835.39

1-Week Range:

$802.72

$888.34

52-Week Range:

$558.13

$895.58

Mckesson Corporation Stock (MCK) Company Profile

Name

Mckesson Corporation

Sector

Healthcare (1132)

Industry

Medical Distribution (12)

Phone

972-446-4800

Address

6555 STATE HIGHWAY 161, IRVING, TX

Employee

51,000

Twitter

@McKesson

Next Earnings Date

2024-11-06

Latest SEC Filings

MCK's Discussions on Twitter

Compare MCK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MCK Mckesson Corporation	805.37	102.41B	387.09B	4.23B	6.01B	32.12
COR Cencora Inc	335.31	68.03B	321.33B	1.57B	3.21B	7.9518
CAH Cardinal Health Inc	199.71	48.74B	234.31B	1.61B	4.45B	6.6243
HSIC Henry Schein Inc	72.88	8.44B	12.50B	314.00M	421.00M	2.44
AHG Akso Health Group Adr	1.39	790.85M	2.22M	-5.63M	-1.68M	-0.24

Mckesson Corporation Stock (MCK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-04-24	Resumed	Mizuho	Neutral
Nov-07-24	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-24-24	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-05-24	Reiterated	Leerink Partners	Outperform
Aug-08-24	Reiterated	Mizuho	Neutral
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-03-24	Initiated	Barclays	Overweight
Dec-14-23	Initiated	Wells Fargo	Equal Weight
Mar-31-23	Initiated	Citigroup	Buy
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jul-06-22	Downgrade	Argus	Buy → Hold
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Feb-04-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-07-22	Upgrade	Credit Suisse	Neutral → Outperform
Nov-02-21	Reiterated	Barclays	Overweight
Nov-02-21	Reiterated	BofA Securities	Buy
Nov-02-21	Reiterated	Evercore ISI	Outperform
Nov-02-21	Reiterated	Jefferies	Buy
Mar-30-21	Upgrade	Argus	Hold → Buy
Nov-02-20	Upgrade	Barclays	Equal Weight → Overweight
Aug-04-20	Upgrade	Deutsche Bank	Hold → Buy
May-22-20	Upgrade	Wolfe Research	Peer Perform → Outperform
May-15-20	Upgrade	UBS	Neutral → Buy
Apr-23-20	Resumed	Credit Suisse	Neutral
Mar-18-20	Upgrade	Goldman	Neutral → Buy
Mar-13-20	Upgrade	Guggenheim	Neutral → Buy
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-10-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-12-19	Initiated	Deutsche Bank	Hold
Aug-05-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-22-19	Initiated	Guggenheim	Neutral
Jan-17-19	Initiated	UBS	Neutral
Oct-26-18	Reiterated	Barclays	Equal Weight
Jul-20-18	Downgrade	Robert W. Baird	Outperform → Neutral
May-29-18	Reiterated	Leerink Partners	Mkt Perform
Mar-08-18	Initiated	Barclays	Equal Weight
Feb-27-18	Resumed	BofA/Merrill	Buy
Feb-02-18	Reiterated	Mizuho	Neutral
Jan-24-18	Upgrade	Jefferies	Hold → Buy

View All

Mckesson Corporation Stock (MCK) Latest News

Dec 03, 2025